About Igentify
Igentify is a company based in Ramat Yishai (Israel) founded in 2016. Igentify has raised $10.5 million across 2 funding rounds from investors including European Union and aMoon. Igentify offers products and services including Igentify Access™, Igentify Analyze™, Igentify Insight™, and Igentify Counsel™. Igentify operates in a competitive market with competitors including Zocdoc, Doctolib, Everlywell, Viome and Color, among others.
- Headquarter Ramat Yishai, Israel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Igentify Ltd.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.5 M (USD)
in 2 rounds
-
Latest Funding Round
$10.5 M (USD), Series A
Sep 17, 2019
-
Investors
European Union
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Igentify
Igentify offers a comprehensive portfolio of products and services, including Igentify Access™, Igentify Analyze™, Igentify Insight™, and Igentify Counsel™.
Provides secure access to genetic information for users.
Analyzes genetic data to support healthcare decisions.
Offers interpretations of genetic information for providers.
Guides the use of genetic data in clinical applications.
People of Igentify
Unlock access to complete
Unlock access to complete
Funding Insights of Igentify
Igentify has successfully raised a total of $10.5M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $10.5 million completed in September 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Igentify
Igentify has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and aMoon.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in healthcare are focused on by aMoon.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Igentify
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Igentify
Investment portfolio details for Igentify
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Igentify
Detailed financials for Igentify
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Igentify Comparisons
Peer comparison for Igentify
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Igentify
Igentify operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Zocdoc, Doctolib, Everlywell, Viome and Color, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Healthcare appointments are booked online via Zocdoc's platform.
|
|
| Locked | Locked | Locked |
Doctor appointments are booked via an online platform.
|
|
| Locked | Locked | Locked |
At-home health tests for biomarkers, nutrition, and hormone analysis.
|
|
| Locked | Locked | Locked |
Machine learning-based bioinformatics solutions for health insights are provided.
|
|
| Locked | Locked | Locked |
Cancer care is delivered through a virtual clinic by Color.
|
|
| Locked | Locked | Locked |
Unfilled appointments are managed for healthcare providers through web-based tools.
|
Detailed competitors of Igentify
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Igentify
Complete news archive for Igentify
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Igentify
Igentify was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Igentify is headquartered in Ramat Yishai, Israel. It is registered at Ramat Yishai, Northern District, Israel.
Igentify is a funded company, having raised a total of $10.5M across 2 funding rounds to date.
Igentify was founded in 2016 in Ramat Yishai, Israel, as a biomedical informatics company focused on preventative healthcare. Genomic products and services are offered, including electronic documentation, e-consenting forms, and educational clips for patients. The FamilyFirst test, an expanded carrier screening adapted for the Israeli population, is available through authorized clinics. Over 850 mutations and 260 hereditary diseases are screened using cheek lining DNA samples to support pregnancy planning.
Igentify's top competitors include Zocdoc, Doctolib and Luma Health.
Igentify offers Igentify Access™, Igentify Analyze™, Igentify Insight™, and Igentify Counsel™.
Igentify has 2 investors. Key investors include European Union, and aMoon.